PROBLEMS IN THE ORGANIZATION OF SURVEILLANCE OF SAFE IMMUNIZATION PRACTICE CONDUCTING

Similar documents
BCG. Program Management. Vaccine Quality

Pentabio Vaccine (DTP-HB-Hib)

IMMUNIZATION(Vaccination)

CHILDHOOD VACCINATION

Vaccine safety messages

V F 4 Years N Recovered DT FEVER INJECTION SITE REACTION

Immunization. Historical point

Patient Name DOB Age Sex: Male Female. Address City State Zip. Parent or Guardian Contact Information. Relationship to Child

IMOVAX POLIO POLIOMYELITIS VACCINE (INACTIVATED) Suspension for injection in prefilled syringe

Thailand Expanded Program on Immunization. Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand

COMPOSITION OF VACCINE per 1 ml: not less than 30 OU/ml (not less than 8.0 IU/ml)

Surveillance of adverse events following immunization

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory

Vaccination against pertussis (whooping cough) an update for registered healthcare practitioners Questions and Answers

We ll be our own lifesavers. We ll get the flu vaccine.

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Gardasil Network Development Project GARDASIL VACCINE QUESTIONNAIRE

Frequently asked questions (FAQs) on MR vaccination campaign. Training Workshop for Measles-Rubella Vaccination Campaigns

NASH INTEGRATIVE MEDICINE, INC. DEBORAH J. NASH, MD, FAAFP 245 S. Garber Drive, Tipp City, Ohio Phone: (937) Fax: (937)

IMMUNIZATION REGULATION

BOOSTRIX. Combined diphtheria, tetanus, acellular pertussis vaccine

INTERVIEW GUIDE FOR THE EPI MANAGEMENT LEVEL GENERAL INFORMATION

Are you protected against measles mumps and rubella?

Frequently asked questions (FAQs) on MR vaccination campaign

Welcome to the California Immunization Coalition Education Hour

Expanded Programme on Immunization (EPI):

Immunization Manual Pre-Departure Medical Services Interim Federal Health Program

Summary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017

Health Care Workers (HCWs) in Ireland should have 2 doses of MMR vaccine. Two of the cases in recent outbreaks in Ireland were HCWs.

Background Rationale of resource Please note:

An Insight into the Immunization Coverage for Combined Vaccines in Albania

BOOSTRIX QUALITATIVE AND QUANTITATIVE COMPOSITION PHARMACEUTICAL FORM CLINICAL PARTICULARS. Indications. Dosage and Administration

General Recommendations on Immunization

WHO Recommendations and Guidelines for the Prevention of Perinatal Hepatitis B and Use of Hepatitis B Vaccines

World Health Organization. implementing hpv vaccination programs: practical experience from path. resource from : publication title.

The Green Channel of the Veneto region as a model for vaccine safety monitoring in Italy

I M VACCINATING FOR TWO NOW. IT S A LIFESAVER. Pregnant women and their babies are at risk from flu. Protect you and your baby - get your flu vaccine.

Questions & Answers 1 November 2005 Vaccine Schedule

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

We ll be our lifesaver. We ll get the flu vaccine.

Washington & Jefferson College Report of Medical History

Pregnant? There are many ways to help protect you and your baby. Immunise against: Flu (Influenza) Whooping cough (Pertussis) German measles (Rubella)

About the Alliance to Remove HPV Mandate: Mandate History: Proposed Legislation: Why We Want Proposed Legislation:

SUMMARY OF PRODUCT CHARACTERISTICS

Immunisation. Objectives. Immunity is the protection which the body develops against further damage by an organism or toxin.

IT S A LIFESAVER EVERY YEAR FLU CAUSES SEVERE ILLNESS AND DEATH. GET YOUR FLU VACCINE NOW. IF YOU ARE: worker

Use of abatacept in rheumatoid arthritis - patient information

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory HIBERIX

School-based HPV Immunisation Programs: The WA Experience

PEDIATRIC REGISTRATION FORM

Department of Community. Medicine. University of Baghdad Al Kindy College of Medicine. Midyear Exam - Fourth Stage الرقم:

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Expanded Programme on Immunization (EPI)

1. QUALITATIVE AND QUANTITATIVE COMPOSITION

Patient s Name: Birthdate: (dd/mm/yyyy) Sex: Mailing Address: Phone Number: Family Doctor or Paediatrician. How did you hear about the clinic?

Polio Vaccine Biological Page

Missed Opportunities to Vaccinate- are we guilty? Dr Deirdre Forde MPH MSc in Child Health HSE Dublin Mid Leinster

CLINICAL PHARMACOLOGY INFANRIX DTPa vaccine, induces antibodies against all vaccine components.

INFORMATION AND CONSENT FORM For Adults Aged 18 and Older Additional Facility Sites

Routine Immunization Coverage Survey

Year 7 immunisation. Parent Consent Form

Monitoring Vaccines Introduction. Pia Caduff-Janosa MD May 2013

Expanded Programme on Immunization (EPI)

Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation

Expanded Programme on Immunization (EPI)

Safety monitoring of vaccines. Jeremy Labadie MD vaccine safety specialist

We ll be our lifesaver. We ll get the flu vaccine.

UIP FACT SHEET. Socio - demographic profile PRL. Infant Mortality Rate

This document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo

VACCINATION PASSIVE IMMUNITY

Faculty of Medicine. Applied Vaccination. Hatim Jaber MD MPH JBCM PhD

Targeted Diseases and Immunization. Strategic plan

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

ORIGINAL ARTICLES. Missed opportunities for vaccination in health facilities in Swaziland. Methods

UNICEF s perspective. WHO Informal Consultation to develop further guidance on vaccines for the UNEP-convened INC4 Geneva, 3-4 April 2012

SHOULD VACCINES BE COMPULSORY?

Pertussis immunisation for pregnant women

CRED Technical Brief: Outbreaks in Fragile States. Yellow Fever in Darfur September December 2012

Health and Social Care Workers and Pandemic Influenza

Priorix TM Measles, mumps and rubella vaccine (live, attenuated)

POLIORIX. Poliomyelitis Vaccine (Inactivated) IP. Inactivated Polio Virus Type 3 (Saukett strain)

SESSION SITES MONITORING OF ROUTINE IMMUNIZATION PROGRAM IN BIJAPUR DISTRICT

Training for Inactivated Poliovirus Vaccine (IPV) introduction. Module 6. Inactivated poliovirus vaccine AEFI monitoring

Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors.

NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11

HEALTH EXAMINATION GUIDELINES FOR ENTRY INTO MALAYSIAN HIGHER EDUCATIONAL INSTITUTIONS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Influenza Vaccine Questions and Answers. Influenza Control Program

Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)

'Contagious Comments' Department of Epidemiology

Seasonal Influenza. Provider Information Sheet. Infectious Disease Epidemiology Program

Expanded Programme on Immunization (EPI)

BOOSTRIX -IPV. BOOSTRIX-IPV is a combined diphtheria, tetanus, acellular pertussis (dtpa) and inactivated poliovirus vaccine.

Dr. Cristina Gutierrez, Laboratory Director, CARPHA SARI/ARI SURVEILLANCE IN CARPHA MEMBER STATES

EXPANDED PROGRAM OF IMMUNIZATION (EPI) Definition Program adopted by WHO since l974, it includes child immunization & vaccination of pregnant women.

FACTS ABOUT PERTUSSIS (WHOOPING COUGH)

For Residence Hall Students Only

Immunisations Questions and Answers

Transcription:

ACTA FAC. MED. NAISS. UDK 615.371 Original article ACTA FAC. MED. NAISS. 2005; 22 (1): 21-28 Zoran Veli~kovi}, Dragan Jankovi}, Miodrag Perovi}, Branislav Tiodorovi}, Nata{a Ran~i} Public Health Insitute Ni{ PROBLEMS IN THE ORGANIZATION OF SURVEILLANCE OF SAFE IMMUNIZATION PRACTICE CONDUCTING SUMMARY Immunization is the fastest, most efficient and cheapest prevention of infectious diseases. Thanks to immunization, many diseases have been eradicated, eliminated or brought down to individual cases. In order to achieve the expected effects, it is necessary that vaccination covers high percentage of the population (at least 95% of the planned individuals), but it also needs to be conducted timely. Beside clear legislations in our country, there are still certain reasons (medical and non-medical) because of which children are not immunized. The survey was done in Primary Health Care Center in Ni{, and the children included in the study were born in 2000 and 2001. 954 vaccination records were checked. 155 persons (12,05%) were vaccinated by different schemes and vaccines, and 23 persons (2,41%) were incompletely vaccinated by DPT vaccine. 3 persons (0,31%) have not been vaccinated by DPT at all, while 40 persons have not been vaccinated by MMR vaccine. Speaking of both ages, DPT vaccine immunization started out late. 46% of children born in 2000 and 51,4% of children born in 2001 have not been vaccinated on time. The first re-vaccination was also late, especially in children born in 2000 (18,4%). In most of the cases, the reasons for this have not been noted, but most frequently mentioned is the refusal of parents to bring their children to immunization (42,1%). Unlike DPT vaccination, only 16% of children born in 2000 and 4,7% born in 2001 have not been vaccinated by MMR on time. The safe immunization surveillance is very difficult to monitor due to different codes (not only from 10 th ICD) and, consequently, very long diagnoses of diseases. Only a small namber of the usual post-vaccination reactions is registered, and there have not been cases of side effects or serious reactions that would be contra-indications for further immunization. Key words: immunization, surveillance, post-vaccination reactions INTRODUCTION Immunization is the fastest, most efficient and cheapest prevention of infectious diseases. Thanks to this method, many diseases have been eradicated (Variola vera in the world and Polio in Europe) eliminated or brought down to individual cases. In order to achieve the expected effects, it is necessary that vaccination covers high percentage of the population (at least 95% of the planned individuals ), but it also needs to be given timely. 21

Z. Veli~kovi}, D. Jankovi}, M. Perovi}, B. Tiodorovi}, N. Ran~i} To achieve all this in the process of immunization, all the aspects need to be ensured and monitored, starting from the production (vaccine quality) which is not influenced by the health service, then the preservation and use of vaccines (cold chain principle, ways of using bottles with larger number of doses, keeping them, etc.), safe vaccine application procedures and disposal of the harmful waste, i.e. the waste of the health institutions. Vaccines are basically safe and efficient, but as many biological matter they can produce side effects. That is why the WHO has established the programme for side effects probably caused by immunization monitoring (AEFIs) (1,2). Side effects were classified as the post-vaccine reactions, results of programme mistakes, reactions to vaccination and unknown reasons (3). The significance of immunization and maintaining good quality in our country are historically pointed out as well, and our legislation is in accordance with the international regulations and experience (4,5). Though there are clear legislations and long immunization tradition, still there are reasons out of which children are not immunized. These reasons are divided into two large groups: non-medical and medical. Medical reasons are the results of contraindications for certain vaccines application (5). They could be general and special, temporary and long-lasting, and they are determined according to the characteristics of the vaccines and the state of patients. Their primary goal is not to harm the patient. However, in everyday practice, there are frequent so-called "false" contraindications that could either postpone or prevent the vaccination. Non-medical reasons are a very important factor, since they can endanger this very important prophylactic measure. Most of all, these are mistakes in the immunization organization, shortage of vaccine and not showing for vaccination. The correct setting and respecting the contra-indications protects the patient and enables the timely or alternative protection of the patient, while detection and monitoring (surveillance) of the side effects determine further activities for patients health protection. Both activities are very important for the implementation of the immunization programme and protection from the unjustified criticism (especially by health workers, media, etc). AIMS The aim of the paper was to establish the existence and frequency of the contraindications for primary vaccination by DPT, OPV and MMR vaccines, as well as the revaccination by DPT and OPV, and also to establish the delays in vaccination and revaccination terms and observe the post-vaccine reactions. MATERIAL AND METHODS Medical database of children born in 2000 and 2001 was checked, and the established state was described. Data analysis of the observed variables was processed by the EPI INFO programme package. Ni{ was chosen as the place for survey since the large population lives in it, and there are also vulnerable population groups. This is a University center with the health experts that are against cellular vaccination against pertusis and MMR vaccine. The children born in 2000 and 2001 were chosen as they were born after the dynamic nineties, when the import of the vaccine and its types is still limited, but when there are still opposite information in the legislation regarding age in which the DPT and MMR vaccines should be given. RESULTS During the vaccinated persons database check, the first thing to do was to define the case of the timely vaccination and the post-vaccine reactions. Timely vaccination meant that the DPT and OPV vaccination started after the completion of 2 months of age (though the age of the baby is unclear), and that the rest of the doses have been given within the right periods after the previous ones, and that the MMR vaccine has been given between 12 and 18 months of age. Every state (disease) determined by the doctor examining the vaccinated child has been established as the post-vaccine reaction. Each fourth medical record in the database has been analyzed as the random sample. The size of the sample has been determined by the following formula (3): N = = 400 d 2 0,05 2 z: alpha risk express in z- score p: expected prevalence q: 1-p d: absolute precision This means that it was enough to examine 400 medical records of children born in each of the two years. However, certain system mistakes and limitations were discovered. It was impossible to consider 22

Problems in the organization of surveillance of safe immunization practice conducting all the records since immunization was carried out at the same time, so the records of a certain number of children were unavailable. Also, the records of refugees, IDPs and vulnerable population groups children were separated, as well as the ones of rural and urban population groups. The examined sample is not representative for the post-vaccine reactions since they were rarely presented and not well defined. Some of the outhospital findings could not be presented sistematically and properly in the Questionnaire since the design of the study was based on the expected one, so the Questionnaire needs to be changed for the future surveys. 954 vaccination records have been checked, out of which there were 459 records of children born in 2000 and 495 in 2001. According to the Census from April, 2002, there were no statistically significant differences in gender and number of children in the years they were born. Table 1 presents the number of children who received the DPT vaccine. Out of the total number, 23 (2,41%) were incompletely vaccinated. Only 3 children (0,31%) haven t been vaccinated at all. It is more important whether all 3 doses were applied timely, since, according to WHO recommendations, the vaccination should be completed by the age of 6 months. Table 2 presents whether the vaccination was conducted on time, and it can be seen that in both groups there are large percents of children that haven t been vaccinated on time by the 1st dose of DPT vaccine (46% born in 2000 and 51,4% in 2001). The same is registered at the 1st revaccination in children born in 2000. The reasons for the delay in children born in 2000 are presented in Table 3. The reasons haven t been noted in 37,4% of children for the 1st dose of DPT, 70,7% for the 2 nd dose, 58,1% for the 3 rd dose, and the 1st revaccination hasn t been performed in 51,5% of children. Presence of the acute disease is the reason for postponing in 11% of cases for the 1 st, 14,6% for the 2 nd and 38,7% for the 3 rd and 38,8% for the 1 st revaccination by DPT vaccine. Other diagnoses were the reason for 51,5% of delayed cases for the 1 st dose of DPT vaccine, 14,6% for the 2 nd, 3,2% for the 3 rd and 9,7% for the Table 1. Registered DTP immunization status (3 doses in the 1 st year of life and revaccination after 12 months from the 3 rd dose) Born in 1 st dose 2 nd dose 3 rd dose Rev Yes No (%) Yes No (%) Yes No (%) Yes No (%) 2000 493 1 (0,2) 492 1 (0,2) 487 5 (1) 337 134 (18,4) 2001 449 2 (0,4) 441 8 (1,8) 433 6 (1,4) 394 34 (7,9) Table 2. DPT immunization performed on time Born in 1 st dose 2 nd dose 3 rd dose Rev Yes No (%) Yes No (%) Yes No (%) Yes No (%) 2000 266 227 (46,0) 451 41 (8,3) 456 31 (6,4) 337 134 (28,4) 2001 218 231 (51,4) 417 24 (15,4) 426 7 (1,6) 376 18 (14,6) Table 3. Reasons for postponing or not immunizing with DPT vaccine, generation of children born in 2000. Reason 1 st dose 2 nd dose 3 rd dose Rev Not mentioned Acute diseases Other diagnoses 85 37,4% 29 70,7% 18 58,1% 69 51,5% 25 11,0% 6 14,6% 12 38,7% 52 38,8% 117 51,5% 6 14,6% 1 3,2% 13 9,7% 23

Z. Veli~kovi}, D. Jankovi}, M. Perovi}, B. Tiodorovi}, N. Ran~i} 1 st revaccination. Reasons for the delay in the group of other diagnoses are hyper-bilirubinemia, i.e. jaundice immediately after the birth, recommendations of neurologists due to the so-called "development monitoring", sickness of a brother or a sister who had recently been vaccinated by other vaccines. Table 4 presents the reasons for delay or non-vaccination by DPT vaccine of children born in 2001.The results are similar to the ones of the children born in the previous year. The vaccination has been postponed in 46,7% of cases without any noted reasons. Each 2 nd child hasn t been given the second dose on time, 57,2% 3 rd, and revaccination was late in one third (66,6%) of cases with no explanation. The acute disease was a very rare reason. Other diagnoses were present in 48,1% for the 1 st dose of DPT, 12,5% for the 2 nd, 42,8% for the 3 rd and 16,7% of cases for the delay of the 1 st revaccination. Other diagnoses are similar in this case, too, and they are not the real contraindications (hyper-bilirubinemia jaundice, development monitoring, low birth weight, etc). Table 5 presents the totals of children vaccinated by MMR. Only 1,4% of children born in 2000 and 7,2% born in 2001 haven t been vaccinated. Unlike DPT vaccine, only 16% and 4,7% of children haven t been vaccinated on time. Reasons for delay or non-vaccination (table 6) haven t been noted in 80% of children born in 2000 and 65% born in 2001. Acute diseases were noted as reasons in 12,8% and 10% of cases, and the rest of diagnoses in 6,4% and 25% of cases. Post-vaccine reactions after the application of DPT and MMR vaccines are presented in Tables 7, 8 and 9. Only a small number of the usual reactions is registered, and it is far below the expected ones. There were no registered cases of the rare serious side effects that could represent contraindications for further immunization. Table 4. Reasons for postponing/not immunizing with DPT vaccine, generation of children born in 2001. Reason 1 st dose 2 nd dose 3 rd dose Rev Not mentioned Acute diseases Other diagnoses 108 46,7% 12 50,0% 4 57,2% 12 66,6% 12 5,2% 9 37,5 - - 3 16,7% 111 48,1% 3 12,5% 3 42,8% 2 16,7% Table 5. Registered MMR immunization status and timeliness of immunization (1 st dose between 12 and 18 months of age) Vaccinated On time Year of birth Yes No (%) Yes No (%) 2000 488 7 (1,4) 410 78 (16) 2001 426 33 (7,2) 406 20 (4,7) Table 6. Reasons for postponing/not immunizing with MMR vaccine Year of birth Reason 2000 2001 Not mentioned 63 80,8% 13 65% Acute diseases 10 12,8% 2 10% Other diagnoses 5 6,4% 5 25% 24

Problems in the organization of surveillance of safe immunization practice conducting Vaccine type Born in 2000 Number of pv reactions (%) Table 7. Registered post-vaccine (pv) reactions, by number and type No. of immunization performed Kind of reaction Born in 2001 Number of pv reactions (%) DPT1 5 (1) 493 febrile 3 (0,7) 449 No. of immunization performed Kind of reaction granuloma haematoma swelling DPT2 2 (0,4) 492 febrile 1 (0,2) 441 local erithema febrile DPT3 2 (0,4) 487 1 (0,2) 433 swelling abscess DPTr 1 (0,2) 471 swelling 1 (0,2) 394 swelling MMR 4 (0,8) 488 febrile swelling rash swelling of lymphatic nodes on the neck 0 (-) 426 - Table 8. Registered post-vaccine reaction after 3660 given DPT doses and expected values Symptoms No. of persons % Expected % No/million doses Febricity 8 0,22 up to 44,5% 2186 Swelling, granuloma, 6 0,16 up to 50 % 1639 haematoma Abscess 1 0,03 273 Local erithema 1 0,03 273 Total 16 0,44 4372 Table 9. Registered post-vaccine reaction after 914 given MMR doses and expected values Symptoms No. of persons % Expected % No/million doses Febricity 1 0,11 up to 15% 1094 Local swelling 1 0,11 up to 10 % 1094 Rash 1 0,11 up to 5% 1094 Swelling of lymphatic nodes on the 1 0,11 1094 neck Total 4 0,44 4376 DISCUSSION Immunization is the fastest, most efficient and cheapest prevention of infectious diseases. Thanks to this method, many diseases have been eradicated (Variola vera in the world and Polio in Europe), eliminated or brought down to individual cases. In order to achieve the expected effects, it is necessary that vaccination covers high percentage of the population (at least 95% of the planned individuals), but it also needs to be given timely. 25

Z. Veli~kovi}, D. Jankovi}, M. Perovi}, B. Tiodorovi}, N. Ran~i} Vaccines are basically safe and efficient, but as any biological matter they can produce side effects. That is why the Global Immunization Programme established in 1997 by WHO paid special attention to the monitoring of side effects that follow immunization (Adverse Events Following Immunization-AEFIs) (1). According to this programme, the side effects are: Post-vaccine reactions, such as the usual mild reactions to vaccine, local reactions (pain, swelling, redness), temperature and systemic symptoms which are the results of a normal immune response and rare (side) serious reactions like convulsions, thrombocytopenia, hypotonic-hyposensitive episodes, persistent crying and screaming, anaphylaxis and encephalopathy. Programme mistakes caused by mistakes in transport, keeping, handling an application of the vaccine. Reaction to injection, fear of or pain caused by injecting. Unknown reason, when the cause cannot be determined. Although there are clear legislations in our country, still there are certain reasons out of which children are not immunized. Those reasons can be medical and non-medical. Medical reasons are the results of presence of general or special contraindications for the certain vaccines application. Their aim is not to harm the patient. Contra-indications are set in cases of the acute disease, febrile state, allergy to some vaccine component, in live viral vaccines due to immunodeficiency, pregnancy, and if the person has evolutionary neurological disease, the pertusis vaccine must not be applied, and if the cellular immunity is damaged by the HIV infection then the BCG vaccine must not be applied. However, the so-called "false" contra-indications are more frequent in daily practice. There are: usual mild local reactions (pain, swelling, redness) after earlier vaccinations, mild respiratory tract infections, diarrhea, body temperature lower than 38,5 degrees C, allergy to penicillin, pollen, house dust, asthma, convulsions in the family anamnesis, dermatomicoses, eczema, local skin infections, chronic disease of heart, lungs, liver, kidneys, stable neurological states, jaundice immediately after birth, low birth weight, premature birth, breastfeeding, pregnancy, earlier diseases etc. Non-medical reasons can endanger the immunization. Most frequent are mistakes in the immunization organization, shortage of vaccines and not showing for vaccination. The survey has been done in the Primary Health Care Center in Ni{, since the population in town is large, and there are vulnerable groups of people as well. This is a University Center with the health experts that are against cellular vaccination against pertusis and MMR vaccine. The children born in 2000 and 2001 were chosen as they were born after the dynamic nineties, when the import of the vaccine and its types are still limited, but when there are still opposite information in the legislation regarding the age in which the DPT and MMR vaccines should be given. 954 vaccination records have been checked, out of which there were 459 records of children born in 2000 and 495 in 2001. According to the Census from April, 2002, there were no statistically significant differences in the gender and number of children in the years they were born. Out of the total number of examined records, 115 persons (12,05%) have been vaccinated by different schemes and vaccines (DT, IPV, Pentavax, etc) and 23 persons were either not or incompletely vaccinated (2,414%). 3 (0,31%) persons have not been vaccinated by DPT vaccine at all, whereas 40 persons (4,19%) have not been vaccinated by MMR. In both years the immunization by DPT and thus OPV vaccines started out late. 46% of children born in 2000 and 51,4% in 2001 haven t received the 1 st dose of DPT. The 1 st revaccination is significantly late as well, especially in children born in 2000 (18,4%). The reason is most frequently unnoted, but the most frequently listed is parents not bringing their children for immunization (42,1%). A confusing information regarding group of the acute diseases is that the child was ill for 5 months. The rest of diagnoses were frequently reasons for postponing the vaccination ( the 1 st dosage of DPT vaccine in 51,5% of children born in 2000 and 48,1% born in 2001). There is a variety of diagnoses here, too, the most frequent being "the risk for the baby", "development monitoring", whereas the icterus is the reason of immunization delay in 15,3% of cases. Almost each 4 th child (23,8%) is late for vaccination because of a neurologist s recommendation. It is confusing that there are different recommendations for the same diagnoses regarding the start and way of immunizations, even by doctors of the same specialization. Unlike DPT vaccination, only 16% of children born in 2000 and 4,7% in 2001 weren t vaccinated by MMR on time. The explanation for this is that MMR vaccination could be conducted between 12 and 18 months of age, but it is recommended after turning 12 months. Reasons for the delay have not been noted in 80% of cases of children born in 2000 and 65% of children born in 2001. The acute disease was the reason for the delay in 12,8% and 25% of cases. High percentage of postponing the MMR vaccination was caused by the unresolved problem of the continuous supply (import) of this vaccine. 26

Problems in the organization of surveillance of safe immunization practice conducting Surveillance over the implementation of the safe immunization is very difficult to monitor in the existing conditions, and also because the codes from the 10 th ICD revision are not applied, so very long diagnoses are noted: "Sy. Aspirationem, Anemiae, Hyperbilirubinemia, Development monitoring", "Risk for the baby", etc. Also, the medical records have not been modified, so it is impossible to track the vaccine by the type and manufacturer, especially since the new vaccines have been introduced, i.e. when there are the alternative schemes of immunization. Medical records also do not contain questions about gender, and sometimes it is difficult to distinguish the gender due to similar names. Only a small number of the usual post-vaccine reactions are registered. After the application of DPT vaccine there is only 0,22% of febrile state cases out of the total of 3660 applied doses, and the expected effects could be up to 45% of the total persons vaccinated. 50% of swellings, redness and granulomae at the place of application could also be expected, and only 0,16% were reported. The situation is the same after MMR vaccine immunization. Out of 914 applied doses there were only 4 cases of post-vaccine reactions which is far below the expected result presented in the textbooks. There were no cases of the unwanted, serious reactions that would represent contra-indications for further immunization. CONCLUSION It is impossible to carry our vaccination between 2 and 6 months of age, if we continue with late start of immunizations. Better informing of parents through the joint activities of health workers of all the specialities could improve the timely primary vaccination. The way of organizing the database and medical records of the vaccinated persons needs to be modified and adjusted to the new laws, new vaccines and new manufacturers. Contra-indications needs to be precisely defined, and diagnoses need to be adjusted to the new codes (10 th revision of ICD). There is no joint opinion of different doctors on the advantages of immunization and its start at the certain age. Finally, it is necessary for all the experts (pediatricians, neurologist, neonatologist, immunologists and epidemiologists) at the state level to decide what to do and how to do it, because there is no use of the situation as it is neither for population nor medical professionals. Most probably, only media benefit from it. REFERENCES 1. Global problems for vaccines and immunization, Surveilance of adverse events following immunization (WHO/EPI/Tram/93.02 REV.1) Geneva: WHO, 1997. 2. Immunization focus: Immunization safety surveillance: Guidlines for managers of immunization programmes on reporting and investigations of adverse events following immunization (WPRO/EPI/99.01), Manila, WHO-WPRO, 1999. 3. Supplementary information on vaccine safety. Part 2: Background Rates of adverse events following immunization, Department of Vaccines and Biologicals WHO, Geneva, 2000. 4. Statute about protection of population from infectious diseases that jeopardize whole state, Service note of FRY, 46/96, 1996. 5. Resolution about way of escorting immunization and prevention by medications against determined infectious diseases, Service note of FRY, 27/97, 1997. 27

Z. Veli~kovi}, D. Jankovi}, M. Perovi}, B. Tiodorovi}, N. Ran~i} PROBLEMI U ORGANIZOVANJU NADZORA NAD SPROVO\ENJEM BEZBEDNE IMUNIZACIONE PRAKSE Zoran Veli~kovi}, Dragan Jankovi}, Miodrag Perovi}, Branislav Tiodorovi}, Nata{a Ran~i} Institut za za{titu zdravlja Ni{ SA@ETAK Imunizacija predstavlja najbr`u, najefikasniju i najjeftiniju za{titu od zaraznih bolesti. Zahvaljuju}i imunizaciji mnoge bolesti su eradicirane, eliminisane ili svedene na pojedina~ne slu~ajeve. Da bi se postigli o~ekivani efekti neophodno je vakcinom obuhvatiti visok procenat osoba (najmanje 95% od broja planiranih), ali isto tako i vakcinaciju izvr{iti pravovremeno. I pored postojanja jasnih zakonskih propisa, kod nas ipak postoje odre eni razlozi (medicinski i nemedicinski) neimunizovanja dece. Ispitivanje je ra eno u Domu zdravlja u Ni{u, a izabrana deca su ro ena 2000. i 2001. godine. Ukupno je pregledano 954 kartona vakcinacije. U ukupnom uzorku pregledanih kartona 155 osoba (12,05%) vakcinisano je razli~itim {emama i vakcinama, a nepotpuno je vakcinisano DTP vakcinom 23 osoba (2,41%). Tri osobe (0,31%) nisu uop{te vakcinisane DTP vakcinom, dok MMR vakcinu nije primilo 40 osoba. U oba posmatrana godi{ta postoji ka{njenje sa zapo~injanjem imunizacije DTP vakcinom. Prvu dozu DTP nije primilo na vreme 46,0% dece ro ene 2000. godine, odnosno 51,4% dece ro ene 2001. godine. Ka{njenje je zna~ajno i za prvu revakcinaciju ovom vakcinom, naro~ito kod dece ro ene 2000. godine (18,4%) naj~e{}e nema upisanog razloga za ka{njenje, ali se naj~e{}e navodi neodazivanje roditelja na pozive za imunizaciju (42,1%). Za razliku od vakcinacije DTP vakcinom, samo 16,0% dece ro ene 2000. godine, odnosno 4,7% ro ene 2001. godine, nije vakcinisano na vreme MMR vakcinom. Nadzor nad sprovo enjem bezbedne imunizacije je veoma te{ko pratiti jer se ne primenjuju uvek {ifre iz 10. revizije MKB, pa se upisuju veoma duge dijagnoze bolesti. Registruje se veoma mali broj uobi~ajenih postvakcinalnih reakcija, a nije registrovan ni jedan slu~aj ne`eljenih, ozbiljnih reakcija koje bi bile kontraindikacije za dalju imunizaciju. Klju~ne re~i: imunizacija, nadzor, postvakcinalne reakcije 28